{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:27:18Z","timestamp":1786991238892,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007464","name":"Torsten S\u00f6derbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007464","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-lungfonden","doi-asserted-by":"publisher","award":["20230463"],"award-info":[{"award-number":["20230463"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-lungfonden","doi-asserted-by":"publisher","award":["20230509"],"award-info":[{"award-number":["20230509"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-lungfonden","doi-asserted-by":"publisher","award":["20241133"],"award-info":[{"award-number":["20241133"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-lungfonden","doi-asserted-by":"publisher","award":["20241051"],"award-info":[{"award-number":["20241051"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-lungfonden","doi-asserted-by":"publisher","award":["20210311"],"award-info":[{"award-number":["20210311"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-lungfonden","doi-asserted-by":"publisher","award":["20210519"],"award-info":[{"award-number":["20210519"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010234","name":"Astma- och Allergif\u00f6rbundet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010234","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018861","name":"Konsul Th C Berghs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020651","name":"Cayman Biomedical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020651","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006285","name":"Magnus Bergvalls Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006285","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2022-00796"],"award-info":[{"award-number":["2022-00796"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007435","name":"\u00c5ke Wiberg Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007435","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","award":["831434"],"award-info":[{"award-number":["831434"]}],"id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jaci.2025.07.026","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T15:14:50Z","timestamp":1754925290000},"page":"1669-1678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["IgE-activated human lung mast cells preferentially release prostaglandin D2, thromboxane A2, and cysteinyl-leukotrienes"],"prefix":"10.1016","volume":"156","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0018-700X","authenticated-orcid":false,"given":"Anna-Karin","family":"Johnsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Kolmert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin","family":"R\u00f6nnberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"S\u00e4fholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamdoh","family":"Al-Ameri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Sachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasra","family":"Vali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig E.","family":"Wheelock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven-Erik","family":"Dahl\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar P.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2025.07.026_bib1","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.jaci.2022.03.029","article-title":"Advances in mast cell biology","volume":"149","author":"Boyce","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.07.026_bib2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3389\/fimmu.2014.00569","article-title":"Mast cell mediators: their differential release and the secretory pathways involved","volume":"5","author":"Moon","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.07.026_bib3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nri3690","article-title":"Mast cell secretory granules: armed for battle","volume":"14","author":"Wernersson","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2025.07.026_bib4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/all.14295","article-title":"Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I","volume":"76","author":"Sokolowska","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.07.026_bib5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1600-065X.2007.00512.x","article-title":"Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation","volume":"217","author":"Boyce","year":"2007","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2025.07.026_bib6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/0005-2760(88)90316-5","article-title":"Properties and purification of an arachidonoyl-hydrolyzing phospholipase A2 from a macrophage cell line, RAW 264.7","volume":"963","author":"Leslie","year":"1988","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jaci.2025.07.026_bib7","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/0003-9861(91)90563-X","article-title":"Oxylipin metabolism in the red alga Gracilariopsis lemaneiformis: mechanism of formation of vicinal dihydroxy fatty acids","volume":"290","author":"Gerwick","year":"1991","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jaci.2025.07.026_bib8","doi-asserted-by":"crossref","first-page":"10239","DOI":"10.1021\/acs.analchem.8b01651","article-title":"Lipid mediator quantification in isolated human and guinea pig airways: an expanded approach for respiratory research","volume":"90","author":"Kolmert","year":"2018","journal-title":"Anal Chem"},{"key":"10.1016\/j.jaci.2025.07.026_bib9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1194\/jlr.M030171","article-title":"Lipid mediator metabolic profiling demonstrates differences in eicosanoid patterns in two phenotypically distinct mast cell populations","volume":"54","author":"Lundstrom","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jaci.2025.07.026_bib10","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3389\/fimmu.2018.02193","article-title":"An optimized protocol for the isolation and functional analysis of human lung mast cells","volume":"9","author":"Ravindran","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.07.026_bib11","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000321933","article-title":"Human cord blood\u2013derived mast cells are activated by the Nod1 agonist M-TriDAP to release pro-inflammatory cytokines and chemokines","volume":"3","author":"Enoksson","year":"2011","journal-title":"J Innate Immun"},{"key":"10.1016\/j.jaci.2025.07.026_bib12","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3390\/cells8111372","article-title":"Wnt-3a induces cytokine release in human mast cells","volume":"8","author":"Tebroke","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jaci.2025.07.026_bib13","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1194\/jlr.D090571","article-title":"Quantitative metabolic profiling of urinary eicosanoids for clinical phenotyping","volume":"60","author":"Gomez","year":"2019","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jaci.2025.07.026_bib14","article-title":"COX-1 dependent biosynthesis of 15-hydroxyeicosatetraenoic acid in human mast cells","volume":"1866","author":"Johnsson","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.jaci.2025.07.026_bib15","series-title":"Eicosanoids and other bioactive lipids in cancer, inflammation, and radiation injury 2: part A. Boston (Mass)","first-page":"71","article-title":"Non-enzymatic rearrangement of leukotriene A4 to 5-keto-(7E,9E,11Z,14Z)-eicosatetraenoic acid in aqueous media","author":"Riendeau","year":"1997"},{"key":"10.1016\/j.jaci.2025.07.026_bib16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejphar.2017.12.005","article-title":"Prostaglandin D2 generation from human lung mast cells is catalysed exclusively by cyclooxygenase-1","volume":"819","author":"Baothman","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jaci.2025.07.026_bib17","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/cea.13831","article-title":"Selective inhibition of prostaglandin D2 biosynthesis in human mast cells to overcome need for multiple receptor antagonists: biochemical consequences","volume":"51","author":"Johnsson","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2025.07.026_bib18","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1084\/jem.192.8.1197","article-title":"Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2\u2013nonsteroidal antiinflammatory drugs and transcellular processing","volume":"192","author":"Serhan","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.07.026_bib19","doi-asserted-by":"crossref","first-page":"7954","DOI":"10.1038\/s41598-018-26325-4","article-title":"Comprehensive analysis of the mouse cytochrome P450 family responsible for omega-3 epoxidation of eicosapentaenoic acid","volume":"8","author":"Isobe","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2025.07.026_bib20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-nutr-071813-105747","article-title":"Lipid-metabolizing CYPs in the regulation and dysregulation of metabolism","volume":"34","author":"Bishop-Bailey","year":"2014","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.jaci.2025.07.026_bib21","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1042\/CS20190657","article-title":"Eicosanoid receptors as therapeutic targets for asthma","volume":"135","author":"Powell","year":"2021","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jaci.2025.07.026_bib22","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1073\/pnas.83.12.4464","article-title":"Two types of human mast cells that have distinct neutral protease compositions","volume":"83","author":"Irani","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2025.07.026_bib23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/thx.2008.101683","article-title":"Novel site-specific mast cell subpopulations in the human lung","volume":"64","author":"Andersson","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2025.07.026_bib24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0005-2760(95)00048-H","article-title":"Arachidonic acid metabolism in the human mast cell line HMC-1: 5-lipoxygenase gene expression and biosynthesis of thromboxane","volume":"1257","author":"Macchia","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jaci.2025.07.026_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2023.106761","article-title":"Defining the contractile prostanoid component in hyperosmolar-induced bronchoconstriction in human small airways","volume":"168","author":"Belikova","year":"2023","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.jaci.2025.07.026_bib26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejphar.2013.08.021","article-title":"Antagonising EP1 and EP2 receptors reveal that the TP receptor mediates a component of antigen-induced contraction of the guinea pig trachea","volume":"718","author":"Safholm","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jaci.2025.07.026_bib27","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1152\/jappl.1989.66.4.1685","article-title":"Effect of a thromboxane receptor antagonist on PGD2- and allergen-induced bronchoconstriction","volume":"66","author":"Beasley","year":"1989","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.jaci.2025.07.026_bib28","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1183\/09031936.93.04060667","article-title":"The role of thromboxane in allergen-induced asthmatic responses","volume":"4","author":"Manning","year":"1991","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.07.026_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/JCI165689","article-title":"TXA2 attenuates allergic lung inflammation through regulation of Th2, Th9, and Treg differentiation","volume":"134","author":"Li","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2025.07.026_bib30","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/ni971","article-title":"Mast cell\u2013dependent migration of effector CD8+ T cells through production of leukotriene B4","volume":"4","author":"Ott","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2025.07.026_bib31","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1053\/j.gastro.2020.02.022","article-title":"Prostaglandin E2, produced by mast cells in colon tissues from patients with irritable bowel syndrome, contributes to visceral hypersensitivity in mice","volume":"158","author":"Grabauskas","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2025.07.026_bib32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0005-2760(90)90304-G","article-title":"Characteristics of formation and further metabolism of leukotrienes in the chopped human lung","volume":"1044","author":"Kumlin","year":"1990","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jaci.2025.07.026_bib33","doi-asserted-by":"crossref","first-page":"7866","DOI":"10.1073\/pnas.79.24.7866","article-title":"Human alveolar macrophages produce leukotriene B4","volume":"79","author":"Fels","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2025.07.026_bib34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1748-1716.1980.tb06656.x","article-title":"Identification of 15-hydroxy-5,8,11,13-eicosatetraenoic acid (15-HETE) as a major metabolite of arachidonic acid in human lung","volume":"110","author":"Hamberg","year":"1980","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.jaci.2025.07.026_bib35","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0003-9861(90)90114-E","article-title":"15(S)-Hydroxyeicosatetraenoic acid is the major arachidonic acid metabolite in human bronchi: association with airway epithelium","volume":"282","author":"Kumlin","year":"1990","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jaci.2025.07.026_bib36","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1016\/S0021-9258(18)60719-7","article-title":"Arachidonate 15-lipoxygenase (omega-6 lipoxygenase) from human leukocytes. Purification and structural homology to other mammalian lipoxygenases","volume":"263","author":"Sigal","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2025.07.026_bib37","doi-asserted-by":"crossref","first-page":"15178","DOI":"10.1073\/pnas.0405445101","article-title":"Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial","volume":"101","author":"Chiang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2025.07.026_bib38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2222.2010.03617.x","article-title":"Effects of celecoxib on major prostaglandins in asthma","volume":"41","author":"Daham","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2025.07.026_bib39","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jaci.2013.12.002","article-title":"Effects of selective COX-2 inhibition on allergen-induced bronchoconstriction and airway inflammation in asthma","volume":"134","author":"Daham","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.07.026_bib40","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1016\/j.jaci.2018.10.069","article-title":"Cytokine-induced endogenous production of prostaglandin D2 is essential for human group 2 innate lymphoid cell activation","volume":"143","author":"Maric","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.07.026_bib41","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jaip.2019.02.002","article-title":"Mast cell activation syndrome and mastocytosis: initial treatment options and long-term management","volume":"7","author":"Castells","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.07.026_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2021.106563","article-title":"Divergent PGD2 and leukotriene C4 metabolite excretion following aspirin therapy: ten patients with systemic mastocytosis","volume":"155","author":"Butterfield","year":"2021","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.jaci.2025.07.026_bib43","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.bjp.0706664","article-title":"Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation","volume":"147","author":"Kay","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jaci.2025.07.026_bib44","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1073\/pnas.80.14.4349","article-title":"Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils","volume":"80","author":"Ham","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2025.07.026_bib45","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1124\/mol.62.2.250","article-title":"Cyclic AMP-mediated inhibition of 5-lipoxygenase translocation and leukotriene biosynthesis in human neutrophils","volume":"62","author":"Flamand","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jaci.2025.07.026_bib46","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.jaci.2015.04.002","article-title":"Prostaglandin E2 inhibits mast cell\u2013dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor","volume":"136","author":"Safholm","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.07.026_bib47","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1182\/blood-2005-07-2772","article-title":"Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses","volume":"107","author":"Feng","year":"2006","journal-title":"Blood"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925008449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925008449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T04:35:12Z","timestamp":1780202112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674925008449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0091674925008449"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2025.07.026","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IgE-activated human lung mast cells preferentially release prostaglandin D2, thromboxane A2, and cysteinyl-leukotrienes","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2025.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}